Literature DB >> 26040877

CRISPR, the disruptor.

Heidi Ledford.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26040877     DOI： 10.1038/522020a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  14 in total

1.  CRISPR provides acquired resistance against viruses in prokaryotes.

Authors:  Rodolphe Barrangou; Christophe Fremaux; Hélène Deveau; Melissa Richards; Patrick Boyaval; Sylvain Moineau; Dennis A Romero; Philippe Horvath
Journal:  Science       Date:  2007-03-23       Impact factor: 47.728

2.  Biotechnology. Regulating gene drives.

Authors:  Kenneth A Oye; Kevin Esvelt; Evan Appleton; Flaminia Catteruccia; George Church; Todd Kuiken; Shlomiya Bar-Yam Lightfoot; Julie McNamara; Andrea Smidler; James P Collins
Journal:  Science       Date:  2014-07-17       Impact factor: 47.728

3.  Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product.

Authors:  Y Ishino; H Shinagawa; K Makino; M Amemura; A Nakata
Journal:  J Bacteriol       Date:  1987-12       Impact factor: 3.490

4.  Long stretches of short tandem repeats are present in the largest replicons of the Archaea Haloferax mediterranei and Haloferax volcanii and could be involved in replicon partitioning.

Authors:  F J Mojica; C Ferrer; G Juez; F Rodríguez-Valera
Journal:  Mol Microbiol       Date:  1995-07       Impact factor: 3.501

5.  Multiplex genome engineering using CRISPR/Cas systems.

Authors:  Le Cong; F Ann Ran; David Cox; Shuailiang Lin; Robert Barretto; Naomi Habib; Patrick D Hsu; Xuebing Wu; Wenyan Jiang; Luciano A Marraffini; Feng Zhang
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

6.  Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.

Authors:  Hao Yin; Wen Xue; Sidi Chen; Roman L Bogorad; Eric Benedetti; Markus Grompe; Victor Koteliansky; Phillip A Sharp; Tyler Jacks; Daniel G Anderson
Journal:  Nat Biotechnol       Date:  2014-03-30       Impact factor: 54.908

7.  A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families.

Authors:  Valmik K Vyas; M Inmaculada Barrasa; Gerald R Fink
Journal:  Sci Adv       Date:  2015       Impact factor: 14.136

8.  CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes.

Authors:  Puping Liang; Yanwen Xu; Xiya Zhang; Chenhui Ding; Rui Huang; Zhen Zhang; Jie Lv; Xiaowei Xie; Yuxi Chen; Yujing Li; Ying Sun; Yaofu Bai; Zhou Songyang; Wenbin Ma; Canquan Zhou; Junjiu Huang
Journal:  Protein Cell       Date:  2015-04-18       Impact factor: 14.870

9.  In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system.

Authors:  Danilo Maddalo; Eusebio Manchado; Carla P Concepcion; Ciro Bonetti; Joana A Vidigal; Yoon-Chi Han; Paul Ogrodowski; Alessandra Crippa; Natasha Rekhtman; Elisa de Stanchina; Scott W Lowe; Andrea Ventura
Journal:  Nature       Date:  2014-10-22       Impact factor: 49.962

10.  RNA-programmed genome editing in human cells.

Authors:  Martin Jinek; Alexandra East; Aaron Cheng; Steven Lin; Enbo Ma; Jennifer Doudna
Journal:  Elife       Date:  2013-01-29       Impact factor: 8.140
View more
  69 in total

Review 1.  From hacking the human genome to editing organs.

Authors:  Takamasa Tobita; Jorge Guzman-Lepe; Alexandra Collin de l'Hortet
Journal:  Organogenesis       Date:  2015-11-20       Impact factor: 2.500

Review 2.  Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery.

Authors:  Mehmet Fatih Bolukbasi; Ankit Gupta; Scot A Wolfe
Journal:  Nat Methods       Date:  2016-01       Impact factor: 28.547

Review 3.  Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology.

Authors:  Rachel J Sizemore; Sonja Seeger-Armbruster; Stephanie M Hughes; Louise C Parr-Brownlie
Journal:  J Neurophysiol       Date:  2016-02-17       Impact factor: 2.714

4.  No time to waste--the ethical challenges created by CRISPR: CRISPR/Cas, being an efficient, simple, and cheap technology to edit the genome of any organism, raises many ethical and regulatory issues beyond the use to manipulate human germ line cells.

Authors:  Arthur L Caplan; Brendan Parent; Michael Shen; Carolyn Plunkett
Journal:  EMBO Rep       Date:  2015-10-08       Impact factor: 8.807

Review 5.  2015 Clinical trials update in sickle cell anemia.

Authors:  Natasha Archer; Frédéric Galacteros; Carlo Brugnara
Journal:  Am J Hematol       Date:  2015-10       Impact factor: 10.047

6.  Unwanted mutations: Standards needed for gene-editing errors.

Authors:  J Keith Joung
Journal:  Nature       Date:  2015-07-09       Impact factor: 49.962

7.  The ethics of genome editing in non-human animals: a systematic review of reasons reported in the academic literature.

Authors:  Nienke de Graeff; Karin R Jongsma; Josephine Johnston; Sarah Hartley; Annelien L Bredenoord
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-13       Impact factor: 6.237

8.  Regulating the New: A Consideration of CRISPR and Approaches to Professional Standards of Practitioners of Chinese Medicine in Australia and Accessing the NDIS.

Authors:  Barry R Furrow; Bernadette J Richards
Journal:  J Bioeth Inq       Date:  2017-04-20       Impact factor: 1.352

Review 9.  Somatic Engineering of Oncogenic Chromosomal Rearrangements: A Perspective.

Authors:  Danilo Maddalo; Andrea Ventura
Journal:  Cancer Res       Date:  2016-08-12       Impact factor: 12.701

10.  Technological advances in precision medicine and drug development.

Authors:  Elaine Maggi; Nicole E Patterson; Cristina Montagna
Journal:  Expert Rev Precis Med Drug Dev       Date:  2016-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.